Rocket Pharmaceuticals’ (RCKT) Neutral Rating Reaffirmed at JPMorgan Chase & Co.
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report)‘s stock had its “neutral” rating reissued by stock analysts at JPMorgan Chase & Co. in a report issued on Wednesday, MarketBeat.com reports. Several other research firms have also recently weighed in on RCKT. Leerink Partners reissued a “market perform” rating and issued a $8.00 price objective (down from […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report)‘s stock had its “neutral” rating reissued by stock analysts at JPMorgan Chase & Co. in a report issued on Wednesday, MarketBeat.com reports. Several other research firms have also recently weighed in on RCKT. Leerink Partners reissued a “market perform” rating and issued a $8.00 price objective (down from […]
